Homocitrullination of lysine residues mediated by myeloid-derived suppressor cells in the tumor environment is a target for cancer immunotherapy.
Cook KW, Xue W, Symonds P, Daniels I, Gijon M, Boocock D, Coveney C, Miles AK, Shah S, Atabani S, Choudhury RH, Vaghela P, Weston D, Metheringham RL, Brentville VA, Durrant LG.
Cook KW, et al. Among authors: boocock d.
J Immunother Cancer. 2021 Jul;9(7):e001910. doi: 10.1136/jitc-2020-001910.
J Immunother Cancer. 2021.
PMID: 34321274
Free PMC article.